Clinical Trials

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer (Consortium-IO)


Study ID
VE800-001

NCT Number
NCT04208958 (Click on the NCT number for more information about the trial)

Research Study Number
2019-0752

Principle Investigator
Dr. Gutierrez, Martin

Phase
I

Sponsor
Vedanta Biosciences, Inc.


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now